JKIL delivered yet another robust quarter, driven by new order wins moving into execution. SEBI outcome is awaited post JKIL providing all documents. But this uncertainty is restraining re-rating. Order wins have been robust and JKIL is well placed for earnings led recovery. We maintain BUY. Key risks (1) Adverse SEBI judgment; (2) Government capex slowdown (3) Interest rate hike. We maintain BUY on JKIL with a reduced TP of Rs 322/sh (vs Rs 335/sh earlier). We value JKIL at 10x FY21E EPS. Due to strong order inflows we have increase our FY20/21E Revenue estimate by 10.9/10.9%. Lower EBIDTA margin assumption and higher interest cost has resulted in FY20/21E EPS change by 3.5/(3.8)%.